|
End-of-day quote
Santiago S.E.
|
||
| - CLP | - |
|
| 17/14/17 | Abbott Laboratories : to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
| 16/14/16 | AbbVie : Abbott to buy Latin American drugmaker CFR in $2.9 billion deal | RE |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +5.95% | +4.47% | +67.80% | +141.31% | 1,14800Cr | ||
| +1.25% | +2.83% | +47.47% | +87.16% | 65TCr | ||
| +1.09% | +1.67% | +28.79% | +104.35% | 51TCr | ||
| +0.64% | +2.58% | +54.45% | +66.68% | 38TCr | ||
| +4.45% | +0.23% | +70.46% | +43.73% | 35TCr | ||
| +2.32% | +2.93% | +34.68% | +56.75% | 29TCr | ||
| +1.83% | +0.46% | +3.82% | +27.62% | 26TCr | ||
| +1.52% | +2.90% | +57.74% | +74.87% | 24TCr | ||
| +1.24% | +2.89% | +36.48% | +107.96% | 20TCr | ||
| Average | +2.31% | +1.39% | +44.63% | +78.94% | 44.86TCr | |
| Weighted average by Cap. | +3.00% | +1.50% | +49.86% | +93.20% |
- Stock Market
- Stocks
- CFR Stock
Select your edition
All financial news and data tailored to specific country editions
















